CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $597.54 | $96K | 40,513 |
| 2026-05-07 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 34,288 | ||
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −80 | $582.86 | $47K | 53,392 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,475 | $584.07 | $862K | 51,917 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −994 | $585.18 | $582K | 50,923 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,689 | $586.17 | $990K | 49,234 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,970 | $587.61 | $1.7M | 46,264 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −820 | $588.51 | $483K | 45,444 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −70 | $596.19 | $42K | 45,374 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −202 | $597.54 | $121K | 45,172 |
| 2026-05-07 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 300 | ||
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $576.32 | $46K | 49,933 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $579.12 | $69K | 49,813 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −384 | $580.07 | $223K | 49,429 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −296 | $581.28 | $172K | 49,133 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −159 | $582.73 | $93K | 48,974 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −796 | $583.73 | $465K | 48,178 |
| 2026-05-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −873 | $584.64 | $510K | 47,305 |
Page 109 of 121 · 2,404 trades